Criado, Paulo Ricardo 
; Miot, Hélio Amante; Pincelli, Thais Prota Hussein; Fabro, Alexandre Todorovic
Source: Dermatologic Therapy. Unidades: FM, FMRP
Subjects: COVID-19, OXIGENAÇÃO HIPERBÁRICA, TROMBOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIADO, Paulo Ricardo et al. From dermatological conditions to COVID ‐19:: reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy. Dermatologic Therapy, v. 34, n. 1, 2021Tradução . . Disponível em: https://doi.org/10.1111/dth.14565. Acesso em: 23 maio 2024.APA
Criado, P. R., Miot, H. A., Pincelli, T. P. H., & Fabro, A. T. (2021). From dermatological conditions to COVID ‐19:: reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy. Dermatologic Therapy, 34( 1). doi:10.1111/dth.14565NLM
Criado PR, Miot HA, Pincelli TPH, Fabro AT. From dermatological conditions to COVID ‐19:: reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy [Internet]. Dermatologic Therapy. 2021 ; 34( 1):[citado 2024 maio 23 ] Available from: https://doi.org/10.1111/dth.14565Vancouver
Criado PR, Miot HA, Pincelli TPH, Fabro AT. From dermatological conditions to COVID ‐19:: reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy [Internet]. Dermatologic Therapy. 2021 ; 34( 1):[citado 2024 maio 23 ] Available from: https://doi.org/10.1111/dth.14565
